BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Flores SK, Estrada-Zuniga CM, Thallapureddy K, Armaiz-Peña G, Dahia PLM. Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers. Cancers (Basel) 2021;13:4602. [PMID: 34572828 DOI: 10.3390/cancers13184602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Toledo RA, Jimenez C, Armaiz-Pena G, Arenillas C, Capdevila J, Dahia PLM. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia. Endocr Rev 2023;44:312-22. [PMID: 36301191 DOI: 10.1210/endrev/bnac025] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Li M, Prodanov T, Meuter L, Kerstens MN, Bechmann N, Prejbisz A, Remde H, Timmers HJLM, Nölting S, Talvacchio S, Berends AMA, Fliedner S, Robledo M, Lenders JWM, Pacak K, Eisenhofer G, Pamporaki C. Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 2023;108:397-404. [PMID: 36190922 DOI: 10.1210/clinem/dgac563] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shirali AS, Clemente-Gutierrez U, Huang BL, Lui MS, Chiang YJ, Jimenez C, Fisher SB, Graham PH, Lee JE, Grubbs EG, Perrier ND. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? Surgery 2023;173:26-34. [PMID: 36229248 DOI: 10.1016/j.surg.2022.05.003] [Reference Citation Analysis]
4 Pamporaki C, Prodanov T, Meuter L, Berends AM, Bechmann N, Constantinescu G, Beuschlein F, Remde H, Januszewicz A, Kerstens MN, Timmers HJ, Taïeb D, Robledo M, Lenders JW, Pacak K, Eisenhofer G. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. European Journal of Cancer 2022;169:32-41. [DOI: 10.1016/j.ejca.2022.03.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Igaz P. New Insights in the Genetics and Genomics of Adrenocortical Tumors and Pheochromocytomas. Cancers (Basel) 2022;14:1094. [PMID: 35205841 DOI: 10.3390/cancers14041094] [Reference Citation Analysis]
6 Sarkadi B, Saskoi E, Butz H, Patocs A. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach. Int J Mol Sci 2022;23:1450. [PMID: 35163370 DOI: 10.3390/ijms23031450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Coco D, Leanza S. Von Hippel-Lindau Syndrome: Medical Syndrome or Surgical Syndrome? A Surgical Perspective. J Kidney Cancer VHL 2022;9:27-32. [PMID: 34963877 DOI: 10.15586/jkcvhl.v9i1.206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]